Contributions
443 recent contributions in Hansard
HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019To be very clear, the six-month period relates to imports. It is important to point that out. After the six months, there will be advice from the regulators as to what the new…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019No, just to be clear, I could not possibly agree to that or let the noble Lord draw that conclusion from my comments. What I am saying is that the Government will use whatever…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019My Lords, I know the noble Lord is pushing me to answer that question but there is nothing that I can add to the answer that I have already given. On the impact assessments, I…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019Perhaps I may conclude my final point about Scotland. Ministers in Wales and Scotland have given their consent to these SIs, as I said in my opening remarks. Senior officials in…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019My Lords, of course, if we have a deal, these SIs will not be necessary. Perhaps I may rephrase that. If there is a deal, we do not need these SIs as they relate only to a no-deal…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019My Lords, the noble Lord does have a suspicious mind, and perhaps I was not clear. This is contingency planning and the agreements that will be put in place within the six months…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019Perhaps I may respond briefly to the noble Lord, Lord Winston. I thought that I had made myself clear, but perhaps not clear enough. Research and clinical trials are outside the…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019Research is also outside the scope of these SIs. The noble Lord has tremendous experience in this area, which we appreciate and value. We have a fantastic NHS based on…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019My Lords, I responded to that question on two occasions. I will repeat for the noble Lord that all the processes currently in place will remain; there will not be anything new.…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019I am happy to respond. I hope that I am not repeating the same points, but they are important. Clearly, the noble Lord is finally beginning to understand that there will not be…09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019That the Grand Committee do consider the Quality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019.09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019My Lords, I refer the Grand Committee to the comments that I made at the start of the first SI, which also extend to this SI. I beg to move.09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019My Lords, for two years, the Government have been implementing a significant programme of work to ensure that the UK will be ready, from day one, in all Brexit scenarios, and I…09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019No, my Lords, we are not talking about a gap. We are actually talking about the continuation of what we have in place at the moment. That is why we are making these contingency…09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019No, I am sorry, we have discussed these issues. Many of the same issues are coming up on all three SIs.09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019I thank noble Lords. The discussion has been constructive. Many issues were raised, although, as I said in the previous discussion, many of them are outwith the comments I can…09 Jan 2019HANSARDQuality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019I am afraid that is the only answer I can give, even if it is not one that the noble Lord, Lord Adonis, feels is adequate. If there are issues that I feel I need to write to noble…09 Jan 2019HANSARDHuman Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019No, I am sorry, I must move on.09 Jan 2019HANSARDHuman Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2019I thank the noble Baroness, Lady Thornton, for her intervention; I very much appreciated it. I also thank the noble Lord, Lord Winston, for his suggestion. But as I have already…09 Jan 2019HANSARDHuman Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2019Perhaps that sounds flippant, but they will still be flying. This is a very serious and crucial matter. We are talking about patient safety and organs. We need to ensure that…09 Jan 2019